Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216372
Status:
COMPLETED
Last Update Posted:
2020-11-05
First Post:
2005-09-13
Brief Title:
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Sponsor:
Organization:
Ipsen